CRS
Overvalued by 100.4% based on the discounted cash flow analysis.
Market cap | $5.46 Billion |
---|---|
Enterprise Value | $6.10 Billion |
Dividend Yield | $0.7966 (0.72%) |
Earnings per Share | $2.62 |
Beta | 1.2 |
Outstanding Shares | 49,608,268 |
Avg 30 Day Volume | 757,937 |
Return on Equity | - |
---|---|
Return on Assets | - |
Return on Invested Capital | - |
P/E Ratio | 41.65 |
---|---|
PEG | -62.64 |
Price to Sales | 2.03 |
Price to Book Ratio | 3.66 |
Enterprise Value to Revenue | 2.24 |
Enterprise Value to EBIT | 20.9 |
Enterprise Value to Net Income | 46 |
Total Debt to Enterprise | 0.11 |
Debt to Equity | 0.46 |
No data
No data